Phase III study of NZ-687 in patients with cancer pain.
Latest Information Update: 21 Dec 2021
At a glance
- Drugs NZ-687 (Primary) ; Tramadol
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Nippon Zoki
- 21 Dec 2021 New trial record
Latest Information Update: 21 Dec 2021